| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |